Rhumbline Advisers Synlogic, Inc. Transaction History

Rhumbline Advisers

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$0.42 - $0.68 $285 - $461	679 New	679 $0
Q2 2020 Aug 13, 2020	SELL	$1.59 - $2.51 $38,152 - $60,227	-23,995 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$1.96 - $2.81 $742 - $1,064	-379 Reduced 1.55%	23,995 $62,000
Q3 2019 Oct 23, 2019	BUY	$2.12 - $9.37 $4,740 - $20,951	2,236 Added 10.1%	24,374 $56,000
Q2 2019 Aug 14, 2019	BUY	$6.27 - $9.48 $2,934 - $4,436	468 Added 2.16%	22,138 $201,000
Q1 2019 May 01, 2019	SELL	$7.01 - $10.24 $581 - $849	-83 Reduced 0.38%	21,670 $164,000
Q4 2018 Jan 31, 2019	BUY	$5.95 - $14.49 $40,579 - $98,821	6,820 Added 45.67%	21,753 $152,000
Q3 2018 Nov 07, 2018	BUY	$7.51 - $14.21 $2,343 - $4,433	312 Added 2.13%	14,933 $212,000
Q2 2018 Aug 06, 2018	BUY	$9.01 - $13.33 $131,735 - $194,897	14,621 New	14,621 $144,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.